Drug adherence and multidisciplinary care in patients with multiple sclerosis: Protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study)

BACKGROUND: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system, for which no definitive treatment is available. Most patients start with a relapsing-remitting course (RRMS). Disease-modifying drugs (DMDs) reduce relapses and disability progression....

Descripción completa

Detalles Bibliográficos
Autores principales: Jongen, Peter J, Hengstman, Gerald, Hupperts, Raymond, Schrijver, Hans, Gilhuis, Job, Vliegen, Joseph H, Hoogervorst, Erwin, van Huizen, Marc, van Munster, Eric, Samijn, Johnny, de Schryver, Els, Siepman, Theodora, Tonk, Martijn, Zandbergen, Eveline, ten Holter, Jacques, van der Kruijk, Ruud, Borm, George
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080802/
https://www.ncbi.nlm.nih.gov/pubmed/21450086
http://dx.doi.org/10.1186/1471-2377-11-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080802/
https://www.ncbi.nlm.nih.gov/pubmed/21450086
http://dx.doi.org/10.1186/1471-2377-11-40

Ejemplares similares